However, many studies have confirmed that the serum indium concentration and the concentration of the Krebs von den Lungen-6 (KL-6), an ILD biomarker, are associated with indium-induced ILD, which serves as the basis for assuming that indium exposure leads to ILD. The gene discussed is MUC1; the disease is interstitial lung disease.